Format

Send to

Choose Destination
HNO. 2005 Jul;53(7):618-22.

[Magnetic Drug Targeting--a new approach in locoregional tumor therapy with chemotherapeutic agents. Experimental animal studies].

[Article in German]

Author information

1
Klinik und Poliklinik für Hals-Nasen-Ohren-Kranke, Universität Erlangen-Nürnberg, 91054 Erlangen. C.Alexiou@web.de

Abstract

BACKGROUND:

Advanced squamous cell carcinomas of the head and neck region were often treated with combined radio-chemotherapy. Radiotherapy allows a focused treatment of the tumor, and healthy tissue can be protected from radiation. Chemotherapy, however, is mostly given systemically and the unwanted negative side effects also develop in many other organs.

AIM OF THE STUDY:

Locoregional application of chemotherapeutic agents with Magnetic Drug Targeting on an animal experimental study.

METHODS AND RESULTS:

Magnetic Drug Targeting is a new approach to the locoregional treatment of tumors. Ferrofluids (colloidal dispersion of magnetic nanoparticles) were reversibly bound to chemotherapeutic agents and injected intra-arterially, while focused with an external magnetic field to a certain body compartment (i.e. the tumor). With only 20% or 50% percent of the regular systemic chemotherapeutic dose, we achieved an up to 26 times higher concentration in the tumor region with this application compared to the usual systemic administration.

CONCLUSION:

Magnetic Drug Targeting offers an unique opportunity to treat tumors locoregionally with chemotherapeutic agents.

PMID:
15549214
DOI:
10.1007/s00106-004-1146-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center